These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35242477)

  • 21. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis.
    Krzewinski JW; Nguyen CD; Foster JM; Burns JL
    J Clin Microbiol; 2001 Oct; 39(10):3597-602. PubMed ID: 11574579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature.
    Cools P; Ho E; Vranckx K; Schelstraete P; Wurth B; Franckx H; Ieven G; Van Simaey L; Van Daele S; Verhulst S; De Baets F; Vaneechoutte M
    BMC Microbiol; 2016 Jun; 16(1):122. PubMed ID: 27342812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Achromobacter Xylosoxidans Bloodstream Infection in Elderly Patient with Hepatocellular Carcinoma: Case Report and Review of Literature.
    Raghuraman K; Ahmed NH; Baruah FK; Grover RK
    J Lab Physicians; 2015; 7(2):124-7. PubMed ID: 26417165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: first French data.
    Amoureux L; Bador J; Siebor E; Taillefumier N; Fanton A; Neuwirth C
    J Cyst Fibros; 2013 Mar; 12(2):170-6. PubMed ID: 22944724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of the species of Achromobacter in a French Cystic Fibrosis Centre and multilocus sequence typing analysis reveal the predominance of A. xylosoxidans and clonal relationships between some clinical and environmental isolates.
    Amoureux L; Bador J; Bounoua Zouak F; Chapuis A; de Curraize C; Neuwirth C
    J Cyst Fibros; 2016 Jul; 15(4):486-94. PubMed ID: 26778615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Community acquired bilateral upper lobe pneumonia with acute adrenal insufficiency: A new face of Achromobacter Xylosoxidans.
    Karanth SS; Gupta A; Prabhu M
    Australas Med J; 2012; 5(10):531-3. PubMed ID: 23173016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phage therapy against Achromobacter xylosoxidans lung infection in a patient with cystic fibrosis: a case report.
    Hoyle N; Zhvaniya P; Balarjishvili N; Bolkvadze D; Nadareishvili L; Nizharadze D; Wittmann J; Rohde C; Kutateladze M
    Res Microbiol; 2018 Nov; 169(9):540-542. PubMed ID: 29777836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Community-acquired Achromobacter xylosoxidans infection presenting as a cavitary lung disease in an immunocompetent patient.
    Hwang CH; Kim WJ; Jwa HY; Song SH
    Yeungnam Univ J Med; 2020 Jan; 37(1):54-58. PubMed ID: 31661759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. L5-S1 Achromobacter xylosoxidans infection secondary to oxygen-ozone therapy for the treatment of lumbosacral disc herniation: a case report and review of the literature.
    Fort NM; Aichmair A; Miller AO; Girardi FP
    Spine (Phila Pa 1976); 2014 Mar; 39(6):E413-6. PubMed ID: 24384664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe Achromobacter xylosoxidans infection and loss of sputum bacterial diversity in an adult patient with cystic fibrosis.
    Talbot NP; Flight WG
    Paediatr Respir Rev; 2016 Aug; 20 Suppl():27-9. PubMed ID: 27374622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis.
    Firmida MC; Pereira RH; Silva EA; Marques EA; Lopes AJ
    Braz J Med Biol Res; 2016; 49(4):e5097. PubMed ID: 26909788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of Achromobacter xylosoxidans in hospital, domestic, and outdoor environmental samples and comparison with human clinical isolates.
    Amoureux L; Bador J; Fardeheb S; Mabille C; Couchot C; Massip C; Salignon AL; Berlie G; Varin V; Neuwirth C
    Appl Environ Microbiol; 2013 Dec; 79(23):7142-9. PubMed ID: 24038696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Native-valve endocarditis caused by
    Rodrigues CG; Rays J; Kanegae MY
    Autops Case Rep; 2017; 7(3):50-55. PubMed ID: 29043211
    [No Abstract]   [Full Text] [Related]  

  • 34. A case of community-acquired spondylodiscitis caused by
    Brochet T; Tonnelier M; Justinien E; Lecapitaine AL; Bouras A
    IDCases; 2024; 36():e01980. PubMed ID: 38737915
    [No Abstract]   [Full Text] [Related]  

  • 35. Severe cellulitis caused by Achromobacter xylosoxidans after allogeneic hematopoietic stem cell transplantation.
    Oyama Y; Yasunaga M; Honda A; Maki H; Masamoto Y; Kobayashi T; Wakabayashi Y; Okugawa S; Moriya K; Kurokawa M
    J Infect Chemother; 2021 May; 27(5):770-772. PubMed ID: 33468424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Achromobacter xylosoxidans keratitis after contact lens usage.
    Park JH; Song NH; Koh JW
    Korean J Ophthalmol; 2012 Feb; 26(1):49-53. PubMed ID: 22323886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with relevant clinical features [corrected] of cystic fibrosis patients.
    Magni A; Trancassini M; Varesi P; Iebba V; Curci A; Pecoraro C; Cimino G; Schippa S; Quattrucci S
    J Clin Microbiol; 2010 Apr; 48(4):1035-9. PubMed ID: 20107101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
    Jain K; Wainwright C; Smyth AR
    Cochrane Database Syst Rev; 2013 Dec; (12):CD009530. PubMed ID: 24363033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients.
    Liu L; Coenye T; Burns JL; Whitby PW; Stull TL; LiPuma JJ
    J Clin Microbiol; 2002 Apr; 40(4):1210-3. PubMed ID: 11923333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of 109 Achromobacter spp. isolates from 9 French CF centres reveals the circulation of a multiresistant clone of A. xylosoxidans belonging to ST 137.
    Amoureux L; Sauge J; Sarret B; Lhoumeau M; Bajard A; Tetu J; Bador J; Neuwirth C;
    J Cyst Fibros; 2019 Nov; 18(6):804-807. PubMed ID: 31104975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.